SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000898432-19-001162
Filing Date
2019-09-11
Accepted
2019-09-11 17:14:20
Documents
4

Document Format Files

Seq Description Document Type Size
1 sc_13da.htm SC 13D/A 49372
2 exh-4.htm EX-4 175095
3 exh-5.htm EX-5 90267
4 csuisse.jpg GRAPHIC 9127
  Complete submission text file 0000898432-19-001162.txt   328690
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Subject) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90473 | Film No.: 191089004
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AMNEAL PHARMACEUTICALS LLC 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address
Patel Chirag K. (Filed by) CIK: 0001738701 (see all company filings)

Type: SC 13D/A